Antibiotics Flashcards
Penicillin G,V
Mechanism?
D-Ala-D-Ala structural analog. Bind penicillin-binding proteins (transpeptidases).
Block transpeptidase cross-linking of peptidoglycan in cell wall.
Activate autolytic enzymes.
Penicillin G,V
Clinical Use?
Mostly used for gram ⊕ organisms (S pneumoniae, S pyogenes, Actinomyces). Also used for gram ⊝
cocci (mainly N meningitidis) and spirochetes (mainly T pallidum). Bactericidal for gram ⊕ cocci,
gram ⊕ rods, gram ⊝ cocci, and spirochetes. β-lactamase sensitive.
Penicillin G,V
Adverse Effects
Hypersensitivity reactions, direct Coombs ⊕ hemolytic anemia, drug-induced interstitial nephritis.
Penicillin G,V
Resistance
β-lactamase cleaves the β-lactam ring. Mutations in PBPs.
Penicillinase-sensitive
penicillins
Examples?
Amoxicillin, ampicillin; aminopenicillins
Penicillinase-sensitive
penicillins
Mechanisms?
Same as penicillin. Wider spectrum;
penicillinase sensitive. Also combine with
clavulanic acid to protect against destruction
by β-lactamase.
AMinoPenicillins are AMPed-up penicillin.
AmOxicillin has greater Oral bioavailability
than ampicillin.
Penicillinase-sensitive
penicillins
Clinical Use?
Extended-spectrum penicillin—H influenzae,
H pylori, E coli, Listeria monocytogenes,
Proteus mirabilis, Salmonella, Shigella,
enterococci.
Coverage: ampicillin/amoxicillin HHELPSS
kill enterococci.
Penicillinase-sensitive
penicillins
Adverse Effects?
Hypersensitivity reactions, rash,
pseudomembranous colitis.
Penicillinase-sensitive
penicillins
Resistance?
Penicillinase (a type of β-lactamase) cleaves
β-lactam ring
Penicillinase-resistant
penicillins
Examples
Dicloxacillin, nafcillin, oxacillin.
Penicillinase-resistant
penicillins
Mechanisms
Same as penicillin. Narrow spectrum;
penicillinase resistant because bulky R group
blocks access of β-lactamase to β-lactam ring.
Penicillinase-resistant
penicillins
Clinical Use
S aureus (except MRSA).
“Use naf (nafcillin) for staph.”
Penicillinase-resistant
penicillins
Adverse Effects
Hypersensitivity reactions, interstitial nephritis
Penicillinase-resistant
penicillins
Resistance
MRSA has altered penicillin-binding protein
target site.
Antipseudomonal
penicillins
Examples?
Piperacillin, ticarcillin.
Antipseudomonal
penicillins
Mechanism?
Same as penicillin. Extended spectrum. Penicillinase sensitive; use with β-lactamase inhibitors.
Antipseudomonal
penicillins
Clinical Use?
Pseudomonas spp. and gram ⊝ rods.
Antipseudomonal
penicillins
Adverse Effects
Hypersensitivity reactions.
Cephalosporins
Mechanism
β-lactam drugs that inhibit cell wall synthesis
but are less susceptible to penicillinases.
Bactericidal
Cephalosporins
What organisms are not covered by 1st-4th generation cephalosporins?
Listeria, Atypicals (Chlamydia, Mycoplasma),
MRSA, and Enterococci
Clinical Use and examples
1st generation Cephalosporins
1st generation (cefazolin, cephalexin)—gram ⊕
cocci, Proteus mirabilis, E coli, Klebsiella
pneumoniae. Cefazolin used prior to surgery to
prevent S aureus wound infections.
1st generation—⊕ PEcK
Clinical Use and examples
2nd generation Cephalosporins
2nd generation (cefaclor, cefoxitin, cefuroxime,
cefotetan)—gram ⊕ cocci, H influenzae,
Enterobacter aerogenes, Neisseria spp., Serratia
marcescens, Proteus mirabilis, E coli, Klebsiella
pneumoniae.
2nd graders wear fake fox fur to tea parties.
2nd generation—⊕ HENS PEcK
Clinical Use and examples
3rd generation Cephalosporins
3rd generation (ceftriaxone, cefotaxime, cefpodoxime, ceftazidime)—serious gram ⊝ infections resistant to other β-lactams.
Can cross blood-brain barrier.
Ceftriaxone—meningitis, gonorrhea,
disseminated Lyme disease.
Ceftazidime—Pseudomonas.
Clinical Use and examples
4th generation Cephalosporins
4th generation (cefepime)—gram ⊝ organisms, with increased activity against Pseudomonas and gram ⊕ organisms.
Clinical Use and examples
5th generation Cephalosporins
5th generation (ceftaroline)—broad gram ⊕ and
gram ⊝ organism coverage; unlike 1st–4th
generation cephalosporins, ceftaroline covers
MRSA, and Enterococcus faecalis—does not
cover Pseudomonas.
Cephalosporins
Adverse effects
Hypersensitivity reactions, autoimmune
hemolytic anemia, disulfiram-like reaction,
vitamin K deficiency. Low rate of crossreactivity even in penicillin-allergic patients.
increase nephrotoxicity of aminoglycosides.
Cephalosporins
Resistance mechanism?
Inactivated by cephalosporinases (a type of
β-lactamase). Structural change in penicillinbinding proteins (transpeptidases).
β-lactamase inhibitors
Examples
Include Clavulanic acid, Avibactam,
Sulbactam, Tazobactam. Often added to
penicillin antibiotics to protect the antibiotic
from destruction by β-lactamase.
CAST (eg, amoxicillin-clavulanate,
ceftazidime-avibactam, ampicillin-sulbactam,
piperacillin-tazobactam).
Carbapenems
Examples
Doripenem, Imipenem, Meropenem, Ertapenem (DIME antibiotics are given when there is a
10/10 [life-threatening] infection).
Carbapenems
Mechanism
What is Imipenem commonly prescribed along with?
Imipenem is a broad-spectrum, β-lactamase–
resistant carbapenem. Always administered
with cilastatin (inhibitor of renal
dehydropeptidase I) to decrease inactivation of drug
in renal tubules.
With imipenem, “the kill is lastin’ with
cilastatin.”
Newer carbapenems include ertapenem (limited
Pseudomonas coverage) and doripenem
Carbapenems
Clinical Use
Gram ⊕ cocci, gram ⊝ rods, and anaerobes.
Wide spectrum and significant side effects
limit use to life-threatening infections or
after other drugs have failed. Meropenem
has a decrease risk of seizures and is stable to
dehydropeptidase I
Carbapenems
Adverse effects
GI distress, rash, and CNS toxicity (seizures) at
high plasma levels.
Carbapenems
Mechanism of resistance
Inactivated by carbapenemases produced by,
eg, K pneumoniae, E coli, E aerogenes
Monobactams
Example
Aztreonam
Monobactams
Mechanism
Less susceptible to β-lactamases. Prevents peptidoglycan cross-linking by binding to penicillinbinding protein 3. Synergistic with aminoglycosides. No cross-allergenicit
Monobactams
Clinical Use
Gram ⊝ rods only—no activity against gram ⊕ rods or anaerobes. For penicillin-allergic patients
and those with renal insufficiency who cannot tolerate aminoglycosides
Monobactams
Adverse effects
Usually nontoxic; occasional GI upset